Cells of Origin for Prostate Cancer
- PMID: 31900905
- DOI: 10.1007/978-3-030-32656-2_4
Cells of Origin for Prostate Cancer
Abstract
Comprehensive knowledge of the normal prostate epithelial lineage hierarchy is a prerequisite to investigate the identity of the cells of origin for prostate cancer. The basal and luminal cells constitute most of the prostate epithelium and have been the major focuses of the study on the cells of origin for prostate cancer. Much progress has been made during the past few decades, mainly using mouse models, to understand the inter-lineage relationship and intra-lineage heterogeneity in adults as well as the lineage plasticity during conditions of stress. These studies have concluded that the adult mouse prostate basal and luminal cells are largely independently sustained under physiological conditions, but both types of cells possess the capacity for bipotent differentiation under stress or artificial experimental conditions. However, the existence or the identity of the putative progenitors within each lineage warrants further investigation. Whether the human prostate lineage hierarchy is completely the same as that of the mouse remains uncertain. Experiments from independent groups have demonstrated that both types of cells in mice and humans can serve as targets for transformation. But controversies remain whether the disease from distinct cells of origin display different clinical behaviors. Further investigation of the intra-lineage heterogeneity will provide new insights into this issue. Understanding the identity of the cells of origin for prostate cancer will help identify novel prognostic markers for early detection of aggressive prostate cancers, provide insights into the therapeutic vulnerability of these tumors, and inspire novel therapeutic strategies.
Similar articles
-
Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.Cancer Cell. 2012 Feb 14;21(2):253-65. doi: 10.1016/j.ccr.2012.01.005. Cancer Cell. 2012. PMID: 22340597 Free PMC article.
-
Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models.Semin Cancer Biol. 2022 Jul;82:60-67. doi: 10.1016/j.semcancer.2021.06.016. Epub 2021 Jun 18. Semin Cancer Biol. 2022. PMID: 34147640 Free PMC article. Review.
-
Prostate stem cells: from development to cancer.Semin Cancer Biol. 2007 Jun;17(3):219-24. doi: 10.1016/j.semcancer.2006.04.004. Epub 2006 May 10. Semin Cancer Biol. 2007. PMID: 16781871 Review.
-
Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential.Stem Cells. 2016 Jan;34(1):191-202. doi: 10.1002/stem.2217. Epub 2015 Oct 27. Stem Cells. 2016. PMID: 26418304 Free PMC article.
-
Multipotent and unipotent progenitors contribute to prostate postnatal development.Nat Cell Biol. 2012 Nov;14(11):1131-8. doi: 10.1038/ncb2600. Epub 2012 Oct 14. Nat Cell Biol. 2012. PMID: 23064263
Cited by
-
Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide.Cancers (Basel). 2023 Jan 4;15(2):332. doi: 10.3390/cancers15020332. Cancers (Basel). 2023. PMID: 36672285 Free PMC article.
-
Heterogeneity and complexity of the prostate epithelium: New findings from single-cell RNA sequencing studies.Cancer Lett. 2022 Jan 28;525:108-114. doi: 10.1016/j.canlet.2021.10.035. Epub 2021 Oct 30. Cancer Lett. 2022. PMID: 34728312 Free PMC article. Review.
-
Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells.Oncogene. 2021 Jan;40(1):203-214. doi: 10.1038/s41388-020-01526-2. Epub 2020 Oct 27. Oncogene. 2021. PMID: 33110232 Free PMC article.
-
Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review.BMC Cancer. 2025 Jan 9;25(1):52. doi: 10.1186/s12885-025-13456-x. BMC Cancer. 2025. PMID: 39789502 Free PMC article.
-
Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers.Int J Mol Sci. 2023 Feb 1;24(3):2830. doi: 10.3390/ijms24032830. Int J Mol Sci. 2023. PMID: 36769153 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous